{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:25:06Z","timestamp":1791264306491,"version":"4.1.0"},"reference-count":26,"publisher":"American Diabetes Association","issue":"suppl_3","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,12,1]]},"abstract":"<jats:p>Accumulation of triglyceride in islets may contribute to the loss of glucose-stimulated insulin secretion (GSIS) in some forms of type 2 diabetes (Diraison et al., Biochem J 373:769\u2013778, 2004). Here, we use adenoviral vectors and oligonucleotide microarrays to determine the effects of the forced expression of SREBP1c on the gene expression profile of rat islets. Sterol regulatory element binding protein-1c (SREBP1c) overexpression led to highly significant (P &amp;lt; 0.1 with respect to null adenovirus) changes in the expression of 1,238 genes or expressed sequence tags, of which 1,180 (95.3%) were upregulated. By contrast, overexpression of constitutively active AMP-activated protein kinase (AMPK), expected to promote lipolysis, altered the expression of 752 genes, of which 702 (93%) were upregulated. To identify specific targets for SREBP1c or AMPK, we eliminated messages that were 1) affected in the same direction by the expression of either protein, 2) changed by less than twofold, or 3) failed a positive false discovery test; 206 SREBP1c-regulated genes (195; 95% upregulated) and 48 AMPK-regulated genes (33; 69% upregulated) remained. As expected, SREBP1c-induced genes included those involved in cholesterol (6), fatty acid (3), and eicosanoid synthesis. Interestingly, somatostatin receptor (sstr1) expression was increased by SREBP1c, whereas AMPK induced the expression of peptide YY, the early endocrine pancreas marker.<\/jats:p>","DOI":"10.2337\/diabetes.53.suppl_3.s84","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"S84-S91","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":28,"title":["Impact of Adenoviral Transduction With SREBP1c or AMPK on Pancreatic Islet Gene Expression Profile"],"prefix":"10.2337","volume":"53","author":[{"given":"Frederique","family":"Diraison","sequence":"first","affiliation":[{"name":"Henry Wellcome Signalling Laboratories and Department of Biochemistry, School of Medical Sciences, University of Bristol, Bristol, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimios","family":"Motakis","sequence":"additional","affiliation":[{"name":"Henry Wellcome Signalling Laboratories and Department of Biochemistry, School of Medical Sciences, University of Bristol, Bristol, U.K"},{"name":"Department of Mathematics, University of Bristol, Bristol, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Parton","sequence":"additional","affiliation":[{"name":"Henry Wellcome Signalling Laboratories and Department of Biochemistry, School of Medical Sciences, University of Bristol, Bristol, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy P.","family":"Nason","sequence":"additional","affiliation":[{"name":"Department of Mathematics, University of Bristol, Bristol, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Leclerc","sequence":"additional","affiliation":[{"name":"Henry Wellcome Signalling Laboratories and Department of Biochemistry, School of Medical Sciences, University of Bristol, Bristol, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy A.","family":"Rutter","sequence":"additional","affiliation":[{"name":"Henry Wellcome Signalling Laboratories and Department of Biochemistry, School of Medical Sciences, University of Bristol, Bristol, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031209080632800_R1","doi-asserted-by":"crossref","unstructured":"Osborne TF: Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J Biol Chem\u2008275:32379\u201332382,2000","DOI":"10.1074\/jbc.R000017200"},{"key":"2022031209080632800_R2","doi-asserted-by":"crossref","unstructured":"Goldstein JL, Rawson RB, Brown MS: Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch Biochem Biophys\u2008397:139\u2013148,2002","DOI":"10.1006\/abbi.2001.2615"},{"key":"2022031209080632800_R3","doi-asserted-by":"crossref","unstructured":"Andreolas C, daSilvaXavier G, Diraison F, Zhao C, Varadi A, Lopez-Casillas F, Ferre\u0301 P, Foufelle F, Rutter GA: Stimulation of acetyl-CoA carboxylase gene expression by glucose requires insulin release and sterol regulatory element binding protein 1c in MIN6 \u03b2-cells. Diabetes\u200851:2536\u20132545,2002","DOI":"10.2337\/diabetes.51.8.2536"},{"key":"2022031209080632800_R4","doi-asserted-by":"crossref","unstructured":"Wang H, Maechler P, Antinozzi PA, Herrero L, Hagenfeldt-Johansson KA, Bjorklund A, Wollheim CB: The transcription factor SREBP-1c is instrumental in the development of beta-cell dysfunction. J Biol Chem\u2008278:16622\u201316629,2003","DOI":"10.1074\/jbc.M212488200"},{"key":"2022031209080632800_R5","doi-asserted-by":"crossref","unstructured":"Schuit F, Flamez D, De Vos A, Pipeleers D: Glucose-regulated gene expression maintaining the glucose-responsive state of beta-cells. Diabetes\u200851 (Suppl. 3):S326\u2013S332,2002","DOI":"10.2337\/diabetes.51.2007.S326"},{"key":"2022031209080632800_R6","doi-asserted-by":"crossref","unstructured":"Diraison F, Parton L, Ferre P, Foufelle F, Briscoe CP, Leclerc I, Rutter GA: Over-expression of sterol regulatory element binding protein-1c or culture with 5-aminoimidazole-4-carboxamide ribonucleoside induces lipogenesis and decreases glucose-stimulated insulin secretion from rat pancreatic islets. Biochem J\u2008373:769\u2013778,2004","DOI":"10.1042\/bj20031277"},{"key":"2022031209080632800_R7","doi-asserted-by":"crossref","unstructured":"Eto K, Yamashita T, Matsui J, Terauchi Y, Noda M, Kadowaki T: Genetic manipulations of fatty acid metabolism in beta-cells are associated with dysregulated insulin secretion. Diabetes\u200851 (Suppl. 3):S414\u2013S420,2002","DOI":"10.2337\/diabetes.51.2007.S414"},{"key":"2022031209080632800_R8","doi-asserted-by":"crossref","unstructured":"Robertson RP, Harmon J, Tran PO, Poitout V: Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes\u200853:S119\u2013S124,2004","DOI":"10.2337\/diabetes.53.2007.S119"},{"key":"2022031209080632800_R9","doi-asserted-by":"crossref","unstructured":"Prentki M, Corkey BE: Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM?Diabetes\u200845:273\u2013283,1996","DOI":"10.2337\/diabetes.45.3.273"},{"key":"2022031209080632800_R10","doi-asserted-by":"crossref","unstructured":"Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, Goldstein JL: Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A\u2008100:12027\u201312032,2003","DOI":"10.1073\/pnas.1534923100"},{"key":"2022031209080632800_R11","doi-asserted-by":"crossref","unstructured":"Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, Hardie DG: Complexes between the LKB1 tumor suppressor, STRADalpha\/beta and MO25alpha\/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol\u20082:28,2003","DOI":"10.1186\/1475-4924-2-28"},{"key":"2022031209080632800_R12","doi-asserted-by":"crossref","unstructured":"Rutter GA, Da Silva Xavier G, Leclerc I: Roles of 5\u2032-AMP-activated protein kinase (AMPK) in mammalian glucose homeostasis. Biochem J\u2008375:1\u201316,2003","DOI":"10.1042\/bj20030048"},{"key":"2022031209080632800_R13","doi-asserted-by":"crossref","unstructured":"Leclerc I, Kahn A, Doiron B: The 5\u2032-AMP-activated protein kinase inhibits the transcriptional stimulation by glucose in liver cells, acting through the glucose response complex. FEBS Lett\u2008431:180\u2013184,1998","DOI":"10.1016\/S0014-5793(98)00745-5"},{"key":"2022031209080632800_R14","doi-asserted-by":"crossref","unstructured":"Salt IP, Johnson G, Ashcroft SJ, Hardie DG: AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. Biochem J\u2008335:533\u2013539,1998","DOI":"10.1042\/bj3350533"},{"key":"2022031209080632800_R15","doi-asserted-by":"crossref","unstructured":"daSilvaXavier G, Leclerc I, Salt IP, Doiron B, Hardie DG, Kahn A, Rutter GA: Role of AMP-activated protein kinase in the regulation by glucose of islet beta-cell gene expression. Proc Natl Acad Sci U S A\u200897:4023\u20134028,2000","DOI":"10.1073\/pnas.97.8.4023"},{"key":"2022031209080632800_R16","doi-asserted-by":"crossref","unstructured":"daSilvaXavier G, Leclerc I, Varadi A, Tsuboi T, Moule SK, Rutter GA: Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression. Biochem J\u2008371:761\u2013774,2003","DOI":"10.1042\/bj20021812"},{"key":"2022031209080632800_R17","doi-asserted-by":"crossref","unstructured":"Leclerc I, Woltersdorf WW, Da Silva Xavier G, Rowe RL, Cross SE, Korbutt GS, Rajotte RV, Smith R, Rutter GA: Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: impact on glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab\u2008286:E1023\u2013E1031,2004","DOI":"10.1152\/ajpendo.00532.2003"},{"key":"2022031209080632800_R18","doi-asserted-by":"crossref","unstructured":"Leclerc I, Rutter GA: AMP-activated protein kinase: a new \u03b2-cell glucose sensor? Regulation by amino acids and calcium ions. Diabetes\u200853 (Suppl. 3):S67\u2013S74,2004","DOI":"10.2337\/diabetes.53.suppl_3.S67"},{"key":"2022031209080632800_R19","doi-asserted-by":"crossref","unstructured":"Hoyle DC, Rattray M, Jupp R, Brass A: Making sense of microarray data distributions. Bioinformatics\u200818:576\u2013584,2002","DOI":"10.1093\/bioinformatics\/18.4.576"},{"key":"2022031209080632800_R20","doi-asserted-by":"crossref","unstructured":"Storey JD: A direct approach to false discovery rates. J R Stat Soc, Series B\u200864:479\u2013498,2002","DOI":"10.1111\/1467-9868.00346"},{"key":"2022031209080632800_R21","doi-asserted-by":"crossref","unstructured":"Akli S, Chelly J, Lacorte JM, Poenaru L, Kahn A: Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments. Genomics\u200811:124\u2013134,1991","DOI":"10.1016\/0888-7543(91)90109-R"},{"key":"2022031209080632800_R22","doi-asserted-by":"crossref","unstructured":"Tsuboi T, DaSilva XG, Leclerc I, Rutter GA: 5\u2032 AMP-activated protein kinase controls insulin-containing secretory vesicle dynamics. J Biol Chem\u2008278:52042\u201352051,2003","DOI":"10.1074\/jbc.M307800200"},{"key":"2022031209080632800_R23","doi-asserted-by":"crossref","unstructured":"Upchurch BH, Aponte GW, Leiter AB: Expression of peptide YY in all four islet cell types in the developing mouse pancreas suggests a common peptide YY-producing progenitor. Development\u2008120:245\u2013252,1994","DOI":"10.1242\/dev.120.2.245"},{"key":"2022031209080632800_R24","doi-asserted-by":"crossref","unstructured":"Kumar U, Sasi R, Suresh S, Patel A, Thangaraju M, Metrakos P, Patel SC, Patel YC: Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes\u200848:77\u201385,1999","DOI":"10.2337\/diabetes.48.1.77"},{"key":"2022031209080632800_R25","doi-asserted-by":"crossref","unstructured":"Gundlach AL: Galanin\/GALP and galanin receptors: role in central control of feeding, body weight\/obesity and reproduction?Eur J Pharmacol\u2008440:255\u2013268,2002","DOI":"10.1016\/S0014-2999(02)01433-4"},{"key":"2022031209080632800_R26","doi-asserted-by":"crossref","unstructured":"Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes\u200852:102\u2013110,2003","DOI":"10.2337\/diabetes.52.1.102"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/53\/suppl_3\/S84\/380222\/zdb11204000s84.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/53\/suppl_3\/S84\/380222\/zdb11204000s84.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T17:01:10Z","timestamp":1736874070000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/53\/suppl_3\/S84\/13891\/Impact-of-Adenoviral-Transduction-With-SREBP1c-or"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,1]]},"references-count":26,"journal-issue":{"issue":"suppl_3","published-print":{"date-parts":[[2004,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.53.suppl_3.s84","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,1]]}}}